Analysis of leucocyte populations with the Coulter S-Plus STKR as a screening tool for haematological abnormalities(131 visite) d'Onofrio G, Salvati AM, Berti P, Cappabianca MP, Marsili G, Quarantelli M, Zini G, Casini C, De Philippis C, Mango G
Parole chiave: Clinical Sensitivity, Coulter Stkr, Leucocyte Differential Count, Three-Part Differential Count, Adult, Article, Controlled Study, Coulter Counter, Female, Human, Human Tissue, Leukocyte Differential Count, Priority Journal, Evaluation Studies, Hematologic Diseases, Leukocyte Count, Mass Screening, Predictive Value Of Tests, Prevalence, Reference Values, Sensitivity And Specificity,
Servizio di Ematologia, Univ. Cattolica Sacro Cuore, Largo Francesco Vito 1, I-00168 Roma, Italy
In two institutions at Rome and Florence we evaluated the clinical sensitivity of two Coulter STKR systems using the NCCLS standard H20-T for leucocyte differential count in a patient population with high prevalence of haematologic abnormalities. Reference ranges of normal leucocytes were obtained on 278 adult subjects. On a population of 455 patient specimens, 200 specimens (44%) were flagged by the STKR because of a distributional abnormality, and 122 (27%) because of a morpholoigical abnormality. Percentage of subtotal agreements between the STKR and the reference manual differential count was 85.4%, with 67.5% full and 20.9% partial agreements. Eight specimens that showed a morphological abnormality with the reference manual differential count were classified as normal by the STKR, with a false normal rate of 6.6%. Analysis of the STKR performance for morphological abnormalities showed acceptable sensitivity (82.0%) and rather low specificity (71.5%), low predictive value of positive results (51.3), high predictive value of negative results (91.5%) and efficiency of 74.3%. The main problems of the STKR differential count were a high rate of false monocyte count, and the misidentification of eosinophilias and low-concentration abnormal cells.
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(78 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M * The EEE project(207 visite) Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980. Impact Factor:0 DettagliEsporta in BibTeXEsporta in EndNote
810 Records (771 escludendo Abstract e Conferenze). Impact factor totale: 3053.378 (2918.233 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 3254.762 (3102.053 escludendo Abstract e Conferenze).